Biography
Carin A. Uyl-de Groot studied Health Care Policy and Management at the Erasmus University Rotterdam. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health Care Policy and Management at the Erasmus Medical Centre Rotterdam. Her research activities are mainly focused on cost-effectiveness analyses of cancer treatments. Quality of life studies are an integral part of these studies. From 1994 she is program leader of cancer studies. Her main interest consists of diagnostics and therapeutic technologies, economic studies linked to clinical studies, modelling studies, cost studies, quality of life studies, methodological issues and implementation studies particularly in the cancer field. She got her PhD in 1995. Since March 2000 she is director of the institute for Medical Technology Assessment. Since November 2005 she has been appointed professor of health technology assessment at the VU University Medical Center in Amsterdam.
Researcher
Erasmus School of Health Policy & Management
Full professor | Health Technology Assessment (HTA)
- uyl@eshpm.eur.nl
More information
Work
- Milanne Maria Johanna Galekop, Philip C. Calder, Ella J. Baker, Joanna Góralska, Urszula Raźny, Malgorzata Malczewska-Malec, Carin A. Uyl-de Groot & William Ken Redekop (2025) - Cost-Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK - Journal of Human Nutrition and Dietetics, 38 (3) - doi: 10.1111/jhn.70071 - [link]
- Sjoerd J.F. Hermans, Jurjen Versluis, Erik D. van Werkhoven, Yvette van Norden, Jeroen J.W.M. Janssen, Gerwin A. Huls, Thomas Pabst, Dimitri A. Breems, Elizabeth Berkx, Avinash G. Dinmohamed, Peter C. Huijgens, Eric Sträng, Jesús María Hernández Rivas, Marta Sobas, Rosa Ayala Diaz, Joaquin Martinez Lopez, Klaus H. Metzeler, Torsten Haferlach, Christian Thiede, Carin A. Uyl-de Groot, Lars Bullinger, Bob Löwenberg, Gert J. Ossenkoppele, Francesco Pignatti & Jan J. Cornelissen (2025) - Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients - British Journal of Haematology - doi: 10.1111/bjh.20185 - [link]
- Katharina Abraham, Isaac Corro Ramos, C. Louwrens Braal, Talitha Feenstra, Anne Kleijburg, George A. K. van Voorn & Carin Uyl-de Groot (2025) - Under-reporting of Validation Efforts for Health Economic Models Persists Despite the Availability of Validation Tools: A Systematic Review - PharmacoEconomics - doi: 10.1007/s40273-025-01491-2 - [link]
- Leonarda Gm Bremmers, Leona Hakkaart-van Roijen, Carin A. Uyl-de Groot & Isabelle N. Fabbricotti (2025) - Informal care provision for mental versus somatic disorders in the Netherlands: a cross-sectional investigation of caregiving context and quality of life outcomes - BMJ open, 15 (4) - doi: 10.1136/bmjopen-2025-099565 - [link]
- Saskia de Groot, Hedwig M. Blommestein, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Pieter H.M. van Baal (2025) - Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma - Medical Decision Making, 45 (3), 302-317 - doi: 10.1177/0272989X251319338 - [link]
- Carlos Antonio Godoy Junior, Laura Mäkitie, Eleonora Fiorenzato, Maija Koivu, Joonas Niskala, Angelo Antonini, Lytske Jantien Bakker, Luis Pilli, Carin Uyl-de Groot, William Ken Redekop & Welmoed Kirsten van Deen (2025) - Diverse preferences, different solutions: Exploring remote monitoring preferences in Parkinson's disease through a discrete choice experiment - Journal of Parkinson's Disease, 1877718X251327752 - doi: 10.1177/1877718X251327752
- Hedwig M. Blommestein, Saskia de Groot, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Margreet G. Franken (2025) - Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model - European Journal of Cancer, 218 - doi: 10.1016/j.ejca.2024.115071 - [link]
- Sydney Howe, Carin Uyl-De Groot & Rik Wehrens (2025) - Legitimacy as Social Infrastructure: A Critical Interpretive Synthesis of the Literature on Legitimacy in Health and Technology - JMIR Human Factors, 12 - doi: 10.2196/48955 - [link]
- Yi Hsuan Chen, Michiel Kroesen, Mischa Hoogeman, Matthijs Versteegh, Carin Uyl-de Groot & Hedwig M. Blommestein (2025) - Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study - Clinical and Translational Radiation Oncology, 51 - doi: 10.1016/j.ctro.2025.100913 - [link]
- Dianne Bosch, Kim J.M. van der Velden, Tom Belleman, Welmoed K. van Deen, André M Bergman, Maarten J. van der Doelen, Alfons J M van den Eertwegh, Winald R Gerritsen, Reindert J A van Moorselaar, Diederik M. Somford, Metin Tascilar, Hans M. Westgeest, Carin A Uyl-de Groot, Peter F.A. Mulders, Malou C.P. Kuppen & Inge M. van Oort (2025) - Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Clinical Genitourinary Cancer, 23 (3) - doi: 10.1016/j.clgc.2025.102317 - [link]
- Carin Uyl - de Groot, Ken Redekop, Amir Ansaripour, K. Zendehdel, N. Tadayon & F. Sadeghi (2016) - Use of data-mining to perform a real world cost analysis of HER2-positive breast cancer in Iran
Cie Beoordeling Oncologische Middelen
- Start date approval
- juli 2022
- End date approval
- juli 2025
- Place
- UTRECHT
Gezondheidsraad
- Start date approval
- juli 2022
- End date approval
- juli 2025
- Place
- DEN HAAG
bestuurslid CPO, Erasmus Medisch Centrum
- Start date approval
- juli 2022
- End date approval
- juli 2025
- Place
- ONBEKEND
Master Thesis Eu-HEM
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4560M
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
Master Thesis HE
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
